BlancoFJRegoIRuiz-RomeroCThe role of mitochondria in osteoarthritisNat Rev Rheumatol20117161–16910.1038/nrrheum.2010.213
2.
CampoGMAvenosoACampoSD'AscolaANastasiGCalatroniAMolecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytesBiochimie201092204–21510.1016/j.biochi.2009.10.006
3.
EchtermeyerFBertrandJDreierRMeineckeINeugebauerKFuerstMLeeYJSongYWHerzogCTheilmeierGPapTSyndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritisNat Med2009151072–107610.1038/nm.1998
4.
Garcia-ArnandisIGuillenMIGomarFPelletierJPMartel-PelletierJAlcarazMJHigh mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1beta in osteoarthritic synoviocytesArthritis Res Ther201012R16510.1186/ar3124
5.
GoldringMBOteroMPlumbDADragomirCFaveroMEl HachemKHashimotoKRoachHIOlivottoEBorziRMMarcuKBRoles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritisEur Cell Mater201121202–220
6.
HashimotoKOreffoROGibsonMBGoldringMBRoachHIDNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytesArthritis Rheum2009603303–331310.1002/art.24882
7.
HeinolaTKouriVPClarijsPCiferskaHSukuraASaloJKonttinenYTHigh mobility group box-1 (HMGB-1) in osteoarthritic cartilageClin Exp Rheumatol201028511–518
8.
LittleCBBaraiABurkhardtDSmithSMFosangAJWerbZShahMThompsonEWMatrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis Rheum2009603723–373310.1002/art.25002
9.
LittleCBFosangAJIs cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis—insights from studies of aggrecan and collagen proteolysis?Curr Drug Targets201011561–57510.2174/138945010791011956
10.
Liu-BryanRTerkeltaubRChondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in miceArthritis Rheum2010622004–2012
11.
MarcuKBOteroMOlivottoEBorziRMGoldringMBNF-kappaB signaling: multiple angles to target OACurr Drug Targets201011599–61310.2174/138945010791011938
12.
MirandaKJLoeserRFYammaniRRSumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13J Biol Chem201028531517–3152410.1074/jbc.M110.125898
13.
MiyakiSSatoTInoueAOtsukiSItoYYokoyamaSKatoYTakemotoFNakasaTYamashitaSTakadaSLotzMKUeno-KudoHAsaharaHMicroRNA-140 plays dual roles in both cartilage development and homeostasisGenes Dev2010241173–118510.1101/gad.1915510
14.
PolurILeePLServaisJMXuLLiYRole of HTRA1, a serine protease, in the progression of articular cartilage degenerationHistol Histopathol201025599–608
15.
RasheedZAkhtarNHaqqiTMAdvanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytesRheumatology (Oxford)2011505838–851
16.
van den BergWBOsteoarthritis year 2010 in review: pathomechanismsOsteoarthritis Cartilage201119338–34110.1016/j.joca.2011.01.022
17.
XuLServaisJPolurIKimDLeePLChungKLiYAttenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in miceArthritis Rheum2010622736–274410.1002/art.27582
18.
YangSKimJRyuJHOhHChunCHKimBJMinBHChunJSHypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destructionNat Med201016687–69310.1038/nm.2153
19.
ZreiqatHBelluoccioDSmithMMWilsonRRowleyLAJonesKRamaswamyYVoglTRothJBatemanJFLittleCBS100A8 and S100A9 in experimental osteoarthritisArthritis Res Ther201012R1610.1186/ar2917
